

Pediatrics
Johannes Van Den Anker, MD
Division Chief of Clinical Pharmacology; Vice Chair of Experimental Therapeutics; Evan and Cindy Jones Professor, Pediatric Clinical Pharmacology
Johannes N. van den Anker, MD, PhD, is a renowned pediatric clinical pharmacologist specializing in neonatal and pediatric pharmacology, serving primarily neonates, young infants, and children at Children's National Hospital in Washington, DC. He focuses on developmental and neonatal clinical pharmacology of critical medications, including antibacterial agents such as aminoglycosides, cephalosporins, penicillins, meropenem, and vancomycin, as well as analgesics like fentanyl, morphine, and ibupr
19+
Years in Practice
Credentials
Board Certifications
- Neonatal-Perinatal Medicine (ABMS)
Education & Training
- Erasmus University, Rotterdam — M.D. and Ph.D. in Clinical Pharmacology
- Erasmus University / Sophia Children’s Hospital, Rotterdam — Residency in Pediatrics and Fellowship in Neonatal Medicine
Recognition & Leadership
Leadership Roles
- Vice Chair of Experimental Therapeutics
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Children's National Hospital
Languages
English
Experience
19+ years in practice